Review Article
The Effects of Modified Simiao Decoction in the Treatment of Gouty Arthritis: A Systematic Review and Meta-Analysis
Table 1
Clinical and demographic characteristics of the patients with gouty arthritis.
| Study (ref.) | Number of participants | Age (years) | Intervention | Outcomes | Experimental | Control | Experimental | Control | Experimental | Control | Duration (days) |
| Chen 2011 [12] | 44 | 44 | 48.5 ± 9.26 | 49.01 ± 8.95 | MSD | Colchicine; allopurinol | 14 | SUA; ESR; AEs | Fan and Weng 2016 [13] | 30 | 30 | 48.0 ± 3.8 | 46.0 ± 3.6 | MSD | Meloxicam | 28 | SUA; ESR; CRP; AEs | Fang 2008 [14] | 20 | 20 | 57.35 ± 14.54 | 53.05 ± 14.47 | MSD | Loxoprofen sodium | 5 | SUA; ESR; AEs | Gao et al. 2014 [15] | 35 | 35 | 44.2 ± 7.2 | 39.4 ± 8.1 | MSD | Colchicine; Etocoxib | 7 | SUA; ESR; CRP; AEs | Jia 2010 [16] | 28 | 26 | 43.0 ± 10.8 | 44.0 ± 11.3 | MSD | Colchicine | 14 | SUA; AEs | Li and Zhang 2007 [17] | 40 | 40 | 47.5 ± 3.17 | 46.8 ± 2.74 | MSD | Allopurinol | 14 | SUA | Li and Song 2013 [18] | 35 | 35 | NR | NR | MSD | Diclofenac sodium | 7 | SUA; AEs | Liu 2011 [19] | 30 | 30 | NR | NR | MSD | Allopurinol; nimesulide | 21 | SUA; ESR; CRP; WBC | Luo and Tang 2010 [20] | 30 | 30 | NR | NR | MSD | Colchicine; diclofenac sodium | 3 | SUA | Mi 2016 [21] | 44 | 42 | 46.12 ± 8.21 | 45.42 ± 7.85 | MSD | Allopurinol; nimesulide | 21 | SUA; ESR; CRP | Niu 2008 [22] | 52 | 47 | NR | NR | MSD | Colchicine | 7 | SUA | Renbin et al. 2008 [7] | 60 | 60 | 46.9 ± 3.37 | 46.8 ± 3.24 | MSD | Allopurinol | 30 | SUA; CRP | Shi et al. 2008 [6] | 28 | 25 | 54.0 ± 12.5 | 52.9 ± 13.2 | MSD | Indomethacin; benzbromarone | 14 | SUA; WBC; AEs | Sun 2006 [23] | 36 | 28 | 53.2 ± 7.8 | 54.0 ± 8.3 | MSD | Benzbromarone | 28 | SUA; ESR | Tang et al. 2008 [24] | 30 | 26 | NR | NR | MSD | Colchicine | 15 | SUA; AEs | Wang et al. 2009 [25] | 90 | 88 | NR | NR | MSD | Colchicine; benzbromarone | 14 | SUA; ESR; WBC; AEs | Wang et al. 2016 [26] | 30 | 30 | 36.1 ± 2.8 | 36.7 ± 2.5 | MSD | Colchicine | 14 | SUA; ESR; CRP | Wang et al. 2016 [27] | 32 | 32 | NR | NR | MSD | Allopurinol; NSAIDs | 10 | SUA; ESR; CRP; WBC; AEs | Yu and Huang 2008 [28] | 40 | 40 | 48.2 ± 8.6 | 46.0 ± 9.7 | MSD | Nimesulide; allopurinol | 14 | SUA; AEs | Zeng and Song 2013 [29] | 60 | 58 | NR | NR | MSD | Colchicine; allopurinol | 14 | SUA | Zhang and Chen 2012 [30] | 36 | 28 | 45.2 ± 7.8 | 43.4 ± 8.3 | MSD | Colchicine; allopurinol; Voltaren or celecoxib | 7 | SUA; ESR; WBC; AEs | Zhao and Mai 2008 [31] | 41 | 40 | NR | NR | MSD | Colchicine; allopurinol | 30 | SUA; ESR; WBC; AEs | Zhao 2014 [32] | 48 | 45 | NR | NR | MSD | Colchicine; allopurinol; Voltaren | 7 | SUA; ESR | Zhu 2016 [33] | 49 | 48 | 45.77 ± 7.08 | 45.45 ± 7.18 | MSD | Colchicine | 15 | SUA |
|
|
Note: MSD: modified Simiao decoction; SUA: serum uric acid; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; WBC: white blood cell; AEs: adverse effects; NR, no report. Values are mean ± standard deviation (SD).
|